HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M800558-MCP200v1 8/9/2145    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Google Scholar Articles by Schlatzer, D. M. Articles by Chance, M. R. PubMed PubMed Citation Articles by Schlatzer, D. M. Articles by Chance, M. R. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 8:2145-2158, 2009.
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Urinary Protein Profiles in a Rat Model for Diabetic Complications^*,

Daniela M. Schlatzer, Jean-Eudes Dazard, Moyez Dharsee, Rob M. Ewing^,, Serguei Ilchenko, Ian Stewart, George Christ^¶ and Mark R. Chance^,||

From the Center for Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106,
¶Wake Forest University School of Medicine, Winston-Salem, North Carolina 27101, and
Infochromics, MaRS Centre, Toronto, Ontario M5G 1L7, Canada

Diabetes mellitus is estimated to affect 24 million people in the United States and more than 150 million people worldwide. There are numerous end organ complications of diabetes, the onset of which can be delayed by early diagnosis and treatment. Although assays for diabetes are well founded, tests for its complications lack sufficient specificity and sensitivity to adequately guide these treatment options. In our study, we employed a streptozotocin-induced rat model of diabetes to determine changes in urinary protein profiles that occur during the initial response to the attendant hyperglycemia (e.g. the first two months) with the goal of developing a reliable and reproducible method of analyzing multiple urine samples as well as providing clues to early markers of disease progression. After filtration and buffer exchange, urinary proteins were digested with a specific protease, and the relative amounts of several thousand peptides were compared across rat urine samples representing various times after administration of drug or sham control. Extensive data analysis, including imputation of missing values and normalization of all data was followed by ANOVA analysis to discover peptides that were significantly changing as a function of time, treatment and interaction of the two variables. The data demonstrated significant differences in protein abundance in urine before observable pathophysiological changes occur in this animal model and as function of the measured variables. These included decreases in relative abundance of major urinary protein precursor and increases in pro-alpha collagen, the expression of which is known to be regulated by circulating levels of insulin and/or glucose. Peptides from these proteins represent potential biomarkers, which can be used to stage urogenital complications from diabetes. The expression changes of a pro-alpha 1 collagen peptide was also confirmed via selected reaction monitoring.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?